Intensive Care Unit Syndrome, Tracheal Intubation Morbidity
Conditions
Keywords
BIOLOGICAL MARKERS, INTENSIVE CARE UNIT, MORTALITY, QUALITY OF LIFE, CARDIOVASCULAR
Brief summary
The purpose of this study is to identify within a cohort of ICU patients admitted for severe illness those who are at risk of death in the year following the discharge from ICU.
Detailed description
FROG-ICU is an epidemiological, observational, prospective, multi centric, cohort study designed for description, prognostic and evaluation. This trial includes as a first step a complete registry of patients admitted to the ICU and as a second step, the outcome of the patients at 1 year after they have been discharged alive from ICU. Plasma and urine samples will be with drawn biomarkers measurements at admission and ICU discharge. It is a multicentric study involving 1 center in Belgium et 24 centers in France.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Adult patients hospitalized in ICU * Patients should have been intubated more than 24 hours * or treated with a positive inotropic agent for more than 24 hours (if not ventilated
Exclusion criteria
* age \< 18 years * pregnancy women * Breast-feeding women * Not affiliated with social security * Dying man * End of life patient * Traumatic Brain Injury (IGCS \< 8) * NTBR * vegetative coma * Transplanted for less than year * no french speaking patient * out of france resident * end of life decision during the following
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All cause mortality at one year after ICU discharge | one year |
Secondary
| Measure | Time frame |
|---|---|
| To assess quality of life in the year following a stay in ICU | one year |
| To identify key determinants of cardiovascular morbidity and mortality in the year following a stay in ICU | one year |
| To investigate the performance of plasma biomarkers usually measured in ICU, to assess the risk of death during the stay in ICU and one year after the discharge. | one year |
| To set up a biological collection of plasma and urine, in order to measure new plasma biomarkers in the assessment of prognosis in the year following a stay in ICU. | one year |
| to evaluate social conditions | one year |
Countries
France